Standout Papers

Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma 2023 2026 2024108
  1. Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma (2023)
    Yohann Loriot, Nobuaki Matsubara et al. New England Journal of Medicine

Immediate Impact

29 standout
Sub-graph 1 of 12

Citing Papers

Advances in diagnosis and treatment of bladder cancer
2024 Standout
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout

Works of Séverine Banek being referenced

Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma
2023 Standout

Author Peers

Author Last Decade Papers Cites
Séverine Banek 263 217 142 62 520
Yoshihiro Nakagami 201 220 146 50 562
Keita Tamura 403 177 185 68 619
Michael Autenrieth 251 186 114 44 535
David Hrouda 288 230 138 42 605
Francesca Barbisan 350 200 103 36 557
Rikiya Taoka 250 177 88 62 533
Eduard Roussel 385 166 107 64 552
Marie C. Hupe 340 151 115 56 631
Spyridon P. Basourakos 295 115 163 64 613
Yuto Matsushita 333 225 74 71 495

All Works

Loading papers...

Rankless by CCL
2026